| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of Pharmacokinetic Interference of Moxifloxacin on Cyclosporine and Tacrolimus in Kidney Transplant Recipients
|
Capone, Domenico
|
|
2010
|
50 |
5 |
p. 576-580
|
artikel
|
| 2 |
Antihypertensive Drug Adherence Among 6408 Chinese Patients on Angiotensin-Converting Enzyme Inhibitors in Hong Kong: A Cohort Study
|
Wong, Martin C. S.
|
|
2010
|
50 |
5 |
p. 598-605
|
artikel
|
| 3 |
Comparative Pharmacokinetics of a Once-Daily Tramadol Extended-Release Tablet and an Immediate-Release Reference Product Following Single-Dose and Multiple-Dose Administration
|
Karhu, David
|
|
2010
|
50 |
5 |
p. 544-553
|
artikel
|
| 4 |
Does Therapeutic Equivalence Follow Bioequivalence? A Randomized Trial to Assess Clinical Effects After Switching From Clozaril to Generic Clozapine (Gen-Clozapine)
|
Oluboka, Oloruntoba
|
|
2010
|
50 |
5 |
p. 531-535
|
artikel
|
| 5 |
Effect of Casopitant, a Novel NK-1 Receptor Antagonist, on the Pharmacokinetics and Pharmacodynamics of Steady-State Warfarin
|
Kirby, Lyndon C.
|
|
2010
|
50 |
5 |
p. 566-575
|
artikel
|
| 6 |
Effect of the Bile Acid Sequestrant Colesevelam on the Pharmacokinetics of Pioglitazone, Repaglinide, Estrogen Estradiol, Norethindrone, Levothyroxine, and Glyburide
|
Brown, Karen S.
|
|
2010
|
50 |
5 |
p. 554-565
|
artikel
|
| 7 |
Long-Term Changes in Cyclosporine Pharmacokinetics After Renal Transplantation in Children: Evidence for Saturable Presystemic Metabolism and Effect of NR1I2 Polymorphism
|
Fanta, Samuel
|
|
2010
|
50 |
5 |
p. 581-597
|
artikel
|
| 8 |
Pharmacokinetic Characteristics of Bolus-Administered Mannitol in Patients Undergoing Elective Craniotomy
|
Kaneda, Kotaro
|
|
2010
|
50 |
5 |
p. 536-543
|
artikel
|
| 9 |
Pharmacokinetics and Pharmacodynamics of a Chimeric/Humanized Anti-CD3 Monoclonal Antibody, Otelixizumab (TRX4), in Subjects With Psoriasis and With Type 1 Diabetes Mellitus
|
Wiczling, Paweł
|
|
2010
|
50 |
5 |
p. 494-506
|
artikel
|
| 10 |
Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of a Novel Sorbitol Dehydrogenase Inhibitor in Healthy Participants
|
Landau, Zohar
|
|
2010
|
50 |
5 |
p. 521-530
|
artikel
|
| 11 |
Population Pharmacokinetic/Pharmacodynamic Model for C.E.R.A. in Both ESA-Naïve and ESA-Treated Chronic Kidney Disease Patients With Renal Anemia
|
Chanu, Pascal
|
|
2010
|
50 |
5 |
p. 507-520
|
artikel
|
Tijdschrift beschrijving